SCHEMBL1740518

SCHEMBL1740518

CCCCCC[C@@H](O)[C@@H](C)O[Si](C)(C)C(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 2/20 0.46
CYP2D6 P10635 2/20 0.40
LMNA P02545 2/20 0.40
GMNN O75496 1/20 0.40
POLB P06746 1/20 0.40
THPO P40225 1/20 0.40
MTOR P42345 1/20 0.40
BLM P54132 1/20 0.40
KDM4E B2RXH2 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
CETP P11597 1/20 0.40
HTT P42858 1/20 0.40
UBE2N P61088 1/20 0.40
ABCB1 P08183 1/20 0.36
PTPN1 P18031 1/20 0.35
TRPV1 Q8NER1 1/20 0.34
TRPA1 O75762 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11898965 1.00 SPHK1 (0.46) SPHK1CYP2D6LMNAGMNNPOLB
SCHEMBL1742920 1.00 SPHK1 (0.46) SPHK1CYP2D6LMNAGMNNPOLB
SCHEMBL1740625 0.98 SPHK1 (0.43) SPHK1CYP2D6LMNAGMNNPOLB
SCHEMBL1741192 0.86 LMNA (0.32) LMNACA2
SCHEMBL1741194 0.86 LMNA (0.32) LMNACA2
SCHEMBL29910754 0.81 GPR84 (0.37) SPHK1CYP2D6LMNAGMNNPOLB
SCHEMBL9117823 0.81 GPR84 (0.37) SPHK1CYP2D6LMNAGMNNPOLB
SCHEMBL11899433 0.80 SPHK1 (0.38) SPHK1LMNAPTPN1GPR84FFAR1
SCHEMBL1741180 0.80 SPHK1 (0.38) SPHK1LMNAPTPN1GPR84FFAR1
SCHEMBL8063012 0.79 FAAH (0.37) SPHK1LMNACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120202287-A1 Stem Cell Culture Methods ITI SCOTLAND LIMITED (GB) 2012-08-09 US disclosed
EP-2389436-A2 STEM CELL CULTURE METHODS ITI Scotland Limited (GB) 2011-11-30 EP disclosed
US-20110257911-A1 SYSTEMS AND METHODS FOR DETECTING CHANGES IN ENERGY USAGE IN A BUILDING JOHNSON CONTROLS TECHNOLOGY COMPANY 2011-10-20 US disclosed
WO-2010084300-A2 STEM CELL CULTURE METHODS ITI SCOTLAND LIMITED (GB) 2010-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202287-A1 Stem Cell Culture Methods KIT, SOX18, MCL1 SPHK1 3188/4885CYP2D6 4131/4885LMNA 2410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.